Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00553917 · ClinicalTrials.gov registry record
Study to Evaluate the Effectiveness of Certain Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants During Pregnancy and Evaluate Newborn Outcomes
A clinical trial, sponsored by Indiana University.
- Terminated
- Registry status
- 18
- Enrollment target
NCT00553917 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 18 participants.
The verdict
NCT00553917 was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if during pregnancy, a common group of antidepressant medications (SSRI's) adequately treats the symptoms of depression and to evaluate if there are any effects of these medications on the newborn infant.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00553917
The ClinicalTrials.gov registry entry for NCT00553917 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00553917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00553917 about?
NCT00553917 is a clinical study titled "Study to Evaluate the Effectiveness of Certain Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants During Pregnancy and Evaluate Newborn Outcomes". The purpose of this study is to evaluate if during pregnancy, a common group of antidepressant medications (SSRI's) adequately treats the symptoms of depression and to evaluate if there are any effects of these medications on the newborn infant.
What is the current status of trial NCT00553917?
This trial is currently terminated. The enrollment target is 18 participants. The study started on 2007-11. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT00553917?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.